Special Issue on Use of Antidepressants After Oncological Treatment to Decrease Mortality

Submission Deadline: Feb. 20, 2020

Please click the link to know more about Manuscript Preparation: http://www.crjournal.org/submission

This special issue currently is open for paper submission and guest editor application.

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)
  • Lead Guest Editor
    • Cesar Alonso Verdeja Robles
      Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
  • Guest Editor
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to complete the Guest Editor application.
    • Brenda Lima Navarro
      Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
    • Sofia Cayetana Aguilar Mendez
      Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
    • Blanca Del Rosario Huicochea Fernandez
      Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
    • Sara Itzel Aguirre Cano
      Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
    • Francisco Candia Archundia
      Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
    • Sergio Gonzalez Sosa
      Facultad de Medicina, Gonzalez Sosa, Puebla, Mexico
  • Introduction

    Depressive states are frequent complications among people suffering from cancer. Often depressive symptoms are a normal reaction or a direct effect of such a severe and life-threatening illness. It is therefore not easy to establish when depressive symptoms become a proper disorder and need to be treated with drugs. Current scientific literature reveals that depressive symptoms, even when mild, can have a relevant impact on the course of cancer, reducing the overall quality of life and affecting compliance with anti-cancer treatment, as well as possibly increasing the cancer mortality rate.
    Oncologists and other medical subspecialists often struggle to recognize significant depressive symptoms, in part due to the overlap between depressive symptoms and cancer- and treatment-related neurovegetative symptoms. More than 50 questionnaires have been developed for distress and depression screening. of which have been assessed rigorously. Although the use of distress screening is increasing,most oncologists avoid using long questionnaires to screen for depressive symptoms owing to time and logistical constraints. Ultra-short screening methods focused on depressed mood and anhedonia has been found to have case-finding and screening abilities that match or exceed those of longer instruments.
    Aims and Scope:
    1. Cancer Treatment
    2. Antidepressants
    3. Mortality
    4. Survival Rate
    5. Cancer Patients
    6. Depression

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.crjournal.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.

  • Published Papers

    The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.